IL6 and acute respiratory distress syndrome: Interleukin-6 (IL-6) appears to be the key circulating cytokine associated with worse outcomes in COVID-19-related ARDS and predicts respiratory insufficiency significantly earlier than C-reactive protein (CRP) [12,13,14].